Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trelegy vs Anoro in COPD GOLD B
NCT06474039Phase 3Recruiting
- Sponsor
- Mahidol University
- Start
- Oct 2024
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by Mahidol University. Started Oct 2024; status: recruiting.
02
Drugs
fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06474039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06474039.